Effect of Serum Glycated Albumin on Survival in Diabetic Patients Undergoing Hemodialysis

Effect of Serum Glycated Albumin on Survival in Diabetic Patients Undergoing Hemodialysis - Serum Glycated Albumin on Survival in Diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009036

Enrollment

1000

Registered

2012-10-03

Start date

2012-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic nephropathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diabetic patients 20years or older who are undergoing hemodialysis

Exclusion criteria

Exclusion criteria: 1.Dialysis vintage less than 6 months 2. Liver cirrhosis or hepatocellular carcinoma 3. Hypo- and hyperthyroidism 4. Malignant disease 5. Active infection

Design outcomes

Primary

Measure	Time frame
Patient death	—

Countries

Japan

Contacts

Public ContactKo Hanai

Tokyo Women's Medial University School of Medicine Diabetes Center

hanai.dmc@twmu.ac.jp03-3353-8111

Outcome results